MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities,
current
$173,934K
Cash and cash
equivalents
$74,603K
Prepaid expenses and
other current assets
$7,172K
Accounts receivable
$2,401K
Total current assets
$258,110K
Marketable securities,
non-current
$48,563K
Right-of-use asset
$40,532K
Property and equipment,
net
$4,744K
Other assets
$3,683K
Restricted cash
$3,443K
Total assets
$359,075K
Total liabilities and
stockholders equity
$359,075K
Total stockholders
equity
$256,587K
Total liabilities
$102,488K
Accumulated deficit
-$738,693K
Additional paid-in capital
$995,221K
Operating lease
liability, net of current
$53,615K
Total current
liabilities
$33,032K
Deferred revenue, net of
current
$15,841K
Accumulated other
comprehensive income
$50K
Common stock, par value
of 0.0001 per share...
$9K
Accrued expenses and
other current...
$13,314K
Deferred revenue,
current
$12,493K
Operating lease
liability, current
$6,367K
Accounts payable
$858K
Back
Back
Balance Sheet
source: myfinsight.com
C4 Therapeutics, Inc. (CCCC)
C4 Therapeutics, Inc. (CCCC)